Volume 4, Issue 6, November 2016, Page: 53-56
Discontinuation Pattern Among Intrauterine Contraceptive Device Users at Jos University Teaching Hospital, Jos, Nigeria
Anyaka Charles, Department of Obstetrics and Gynaecology, University of Jos/Jos University Teaching Hospital, Jos, Nigeria
Ocheke Amaka, Department of Obstetrics and Gynaecology, University of Jos/Jos University Teaching Hospital, Jos, Nigeria
Shambe Iornum, Department of Obstetrics and Gynaecology, University of Jos/Jos University Teaching Hospital, Jos, Nigeria
Kahansim Makshwar, Department of Obstetrics and Gynaecology, University of Jos/Jos University Teaching Hospital, Jos, Nigeria
Oyebode Tinuade, Department of Obstetrics and Gynaecology, University of Jos/Jos University Teaching Hospital, Jos, Nigeria
Pam Victor, Department of Obstetrics and Gynaecology, University of Jos/Jos University Teaching Hospital, Jos, Nigeria
Ekwempu Chinedu, Department of Obstetrics and Gynaecology, University of Jos/Jos University Teaching Hospital, Jos, Nigeria
Received: May 13, 2016;       Accepted: Jun. 22, 2016;       Published: Jan. 3, 2017
DOI: 10.11648/j.jgo.20160406.14      View  3775      Downloads  127
Abstract
Context: Despite the high uptake of the intrauterine contraceptive device (IUCD), among family planning clients at Jos University Teaching Hospital (JUTH), some users discontinued its use for a variety of reasons. Objectives: To determine the discontinuation rate and factors responsible among IUCD users in the hospital over a 3 year period. Study Design: This was a 3 year retrospective descriptive study of all clients requesting for the removal of intrauterine devices (IUCDs) at the Family Planning clinic Jos University Teaching Hospital, Jos Nigeria. The study period was between January 1 st 2005 and December 31st 2007. Results: A total of 849 clients were seen during the study period; 393 (46.3%) clients discontinued within 3 years with the highest rate at 1 year 24.2%. All the women were married with 0.8% of the clients been nullipara. The most common reasons for discontinuation were the desire for pregnancy (50.9%), excessive menstrual bleeding (10.4%), vaginal discharge PID (9.0%) and others. The mean age of the clients was 33.6 ± 5.2 years. Conclusion: The discontinuation rate of IUCD in the family planning clinic at Jos University Teaching Hospital is high. More effective counseling may be appropriate for alternative contraceptive methods for this category of clients instead of the IUCD’s currently being used. The findings suggest a need for training the care providers to prevent early discontinuation of IUCD among JUTH clients and by addressing the health challenges via proper counseling, effective follow-up and prompt referral in case of complications.
Keywords
Contraceptives, IUCD, Discontinuation, Jos Nigeria
To cite this article
Anyaka Charles, Ocheke Amaka, Shambe Iornum, Kahansim Makshwar, Oyebode Tinuade, Pam Victor, Ekwempu Chinedu, Discontinuation Pattern Among Intrauterine Contraceptive Device Users at Jos University Teaching Hospital, Jos, Nigeria, Journal of Gynecology and Obstetrics. Vol. 4, No. 6, 2016, pp. 53-56. doi: 10.11648/j.jgo.20160406.14
Copyright
Copyright © 2016 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Salem R. M. Richey C. IUD-An Update. Population Report. Series B No 7 Baltimore, Johns Hopkins school of Public Health, Population Information Program. Feb 2006: 3-27.
[2]
Sekadde – Kigondu C, Mwathe E. E. Ruminjo JK, Nichols, D Jessencky K, Liku J. Acceptability and discontinuation of Depo-Prover, IUCD and combined pills in Kenya. East Afr Med J 1996 73 (12): 786-794.
[3]
Oddens B. J. Women’s satisfaction with birth control. A population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning and sterilization among 1466 women. Contraception. 1999; 59 (5): 277-286.
[4]
Aisien A. O Intrauterine contraceptive device (IUCD), acceptability and effectiveness in a tertiary institution. Afr J Med Sci 2007 Sep; 36 (3): 193-200.
[5]
Cea Soriano L, Wallade MA, Andersson S, Filonenko A, Garcia Rodriguez L. A The continuation rates of long acting reversible contraceptives in UK general practice using data from The Health improvement Network. Pharmacoepidemiol. Drug saf 2014 sept 24. doi: 10.1002/pds.3710
[6]
Gary K. S Intrauterine device. In Contraceptive technology. 17th Edition. Ardent media Inc. 1998: 511-541.
[7]
Tinelli A, Tinelli R, Malvasi A, Cavalloti C, Tinelli F. G The intrauterine device in modern contraceptive. Still an actuality. Eur J Contracept Reprod Health Care. 2006; 11 (3): 197-201.
[8]
Mutihir J. T, Ujah I. A. O, Iranloye T, Uduagbamen P. F. K. Indications for removal of intrauterine devices in Jos North Central Nigeria Niger J Clin Pract 2005; 9 (2): 105-108.
[9]
Okunlola M. A, Owonikoko K. M, Robert O. A. Morhason-Bello T. P Discontinuation pattern among IUCD users at the family planning clinic University College Hopsital, Ibadan. J Obstet Gynaecol. 2006; 26 (2) 152-6.
[10]
Colli. E, Tong. D, Pentallegon. R, Parazzini. F. Reasons for contraceptive discontinuation in women 20-39 years old in New Zealand. Contraception 1999; 59 (4): 227-31.
[11]
Tripathi V, Nandan D, Salhan S. Determinants of early discontinuation of IUCD use in rural northern district of India: a multivariate analysis and its validation. J Biosoc Sci 2005; 37 (3): 319-32.
[12]
Tugrul S, Yavuzer B. Yildirim G, Kayahan A. The duration of use, cause of discontinuation and problems during removal in women admitted for removal of IUD. Contraception. 2005; 71 (2): 149-52.
[13]
Khader Y. S, El-Qaderi S, Khader A. M. Intrauterine contraceptive device discontinuation among Jordanian women: rate, causes and determinants. J fam Plann Reprod Health Care; 2006; 32 (3): 161-4.
[14]
Escudero F, Gonzales G F, Delgadillo L, Villena A. E. Factors associated with discontinuation rates of the copper T 380A IUD in a Peruvian public hospital. Adv contracept 1999; 15 (4): 303-11.
[15]
Jimoh A. A. Complications of intrauterine contraceptive device (IUD) use at the University of Ilorin Teaching Hospital, Ilorin. Niger J Med. 2004; 13 (3) 244-9.
[16]
Badaruddin A, Shallwani S, Hussain F A, Sultana M, Parveen F. Social and personal factors affecting continuation of contraceptive use. 1998, Available at: http/www.mopw.gov.pk/nrifc/socialpers
[17]
Ali M, Cleland J. Contraceptive discontinuation in six developing countries. A cause-specific analysis. International Family Planning 1995; 21: 92–97.
[18]
Marret H, Golfier F, Vollerin F, Legoaziou M. F. Raudrant D. Intrauterine devices in general practice: a prospective study of 300 insertions. J Gynecol obstet Biol Reprod Paris. 2002; 31 (5): 465-70.
[19]
Jenabi E, Alizade S. M, Baga RI. Continuation rates and reasons for discontinuing TCu380A IUD use in Tabriz, Iran. Contraception. 2006; 74 (6): 483-6.
[20]
Shah N. M, Shah M. A, Chowdhury R. I, Menon I. Reasons and correlates of contraceptive discontinuation in Kuwait. Eur J Contraceptive Reprod Health Care: 2007; 12 (3) 260-8.
[21]
Treiman K, Liskin L, Kols A, Rinehart W. IUDs-An update. Population Report. Series B, No 6 Baltmore, Johns Hopkins school of Public Health, Population information program. Dec 1995: 35.
[22]
Farr. G, Amatya R, Acosta M, Ekwempu CC, Kisninci H. Clinical performance of the TCu 380A and Lippes loop IUDs in three developing countries. Contraception. 1995; 52 (1): 17-22.
[23]
Reinprayon D. Gilmore C, Farr G, Amatya R. Twelve-month comparative multicentre study of the TCu 380A and ML 250 intrauterine devices in Bangkok, Thailand. Contraception. 1998; 58 (4): 201-206.
[24]
WHO, Department of Reproductive Health and Research and UNDP/UNFPA/WHO/World bank special programme of research, development and research training in human reproduction. Annual technical report 2003. Geneva, WHO 2003.
[25]
Pakarinen P. I, Toivonen J, Luukkainen T. Randomised comparison of levonorgestrel and copper-releasing intra uterine systems immediately after abortion with 5 years follow-up. Contraception 2003; 68 (1) 31-34.
[26]
Wu S, Hu J, Wildemeersch D. Performance of the frameless gynefix and the TCu 380A IUDs in a 3 year multicentre randomized, comparative trial in parous women. Contraception. 2000; 61 (2): 91-98.
[27]
International planned parenthood federation (IPPF) and World Health Organisation (WHO). The intrauterine device (IUD) (Draft). IPPF and WHO. IPPF/WHO myth monograph. 2001: 21.
[28]
Toma A, Jamieson MA,. Revisiting the intra uterine contraceptive device in adolescents. J Pediatr Adolesc Gynaecol 2006; 19 (4): 291-6.
[29]
Dimkpa O. J, Okwudili O. E, Wamadi N. E Intrauterine Contraceptive Device Use in Port Harcourt, Southern Nigeria: A Retrospective Analysis. British Journal of Medicine & Medical Research 2014; 4 (16): 3132-3139.
Browse journals by subject